Entravision expects ATS revenue to decrease sequentially in Q3 while targeting more than 100% year-over-year growth in Q3 and Q4

Key deals this week: Option Care Health, PTC, Energy Transfer and more

2026/10/10

‘Big Short’ investors split over the AI risk that matters most

2026/10/10

Nvidia in talks to buy ‘open’ model startup Reflection AI: FT

2026/10/10

Better Biotechnology ETF: First Trust FBT vs. VanEck BBH

2026/10/10